Approval · Notice of Compliance 8471 · 2006
BANAMINE SOLUTION INJECTABLE: Notice of Compliance 8471
Issued December 19, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8471
- Date
- December 19, 2006
- Company
- Schering Canada Inc.
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Anti-inflammatory, analgesic, antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BANAMINE SOLUTION INJECTABLE | 00465305 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML